Glenmark Pharmaceuticals Ltd. Share Price

Glenmark Pharmaceuticals Ltd. (INR)1405.15-17.1 (-1.2%)

Exchange ScripsBSE532296NSEGLENMARKISININE935A01035

Stock Performance

Fundamentals

Technicals

Shareholding Patterns

Financials

Similar Stocks

Trendline of performance -

Glenmark Pharmaceuticals Ltd. Performance

Market performance

Open price1422.3

High1422.3

Volumes333781

Prev Close1405.15

Low1398.6

Closing date2025-03-13

Historical performance

1 Year High1830.95

3 Year High1830.95

5 Year High1830.95

1 Year Low908.35

3 Year Low348.50

5 Year Low184.45

Glenmark Pharmaceuticals Ltd. Fundamentals

Company Valuation

Market Cap (₹Cr)

39671

Face Value (₹)

P/E Ratio

-26.41

Dividend Yield

0.18 %

Glenmark Pharmaceuticals Ltd. Investment Returns

1 Year

56.4%

3 Years

210%

5 Years

570.4%

10 Years

67.2%

Glenmark Pharmaceuticals Ltd. Technicals

Indicators	Value	Signal
5-DMA	1407.03	Bearish
10-DMA	1374.63	Bullish
20-DMA	1360.38	Bullish
50-DMA	1442.39	Bearish
100-DMA	1512.56	Bearish
200-DMA	1505.76	Bearish

Shareholding Pattern

Field	Dec-2024	Sep-2024	Jun-2024	Mar-2024	Dec-2023
Promoters	6	6	6	6	6
Foreign Investors	---	---	---	---	---
Domestic Investors	6	6	6	6	6
Public Investors	195053	193943	192624	199445	209925
Government	3	3	3	4	4

Glenmark Pharmaceuticals Ltd. Financials

Below figures are in Rs. Crores

Particulars	Mar-2024	Mar-2023	Mar-2022	Mar-2021
Other Income	8400	2889	1667	502
Operating Profit	20353	19239	24870	21346
Interest	5160	3490	2981	3531
Depreciation	5819	5692	4867	4436
Profit Before Tax	365	2398	14412	13825
Consolidated Net Profit	-15017	2972	9417	9700
Adjusted EPS	-53	11	33	34

Balance Sheet

Below figures are in Rs. Crores

Particulars	Mar-2024	Mar-2023	Mar-2022	Mar-2021
Share Capital	282	282	282	282
Total Reserves	78015	94281	90421	70148
Minority Interest	-4	3653	3515	-4
Total Non-Current Liabilities	-3572	26214	12696	28036
Total Liabilities	133089	175658	153972	140689
Capital Work in Progress	4193	10658	9211	12178
Total Assets	133089	175658	153972	140689

Cash Flow

Below figures are in Rs. Crores

Particulars	Mar-2024	Mar-2023	Mar-2022	Mar-2021
Cash Flow from Operating Activities	-2654	6254	11087	11312
Cash Flow from Investing Activities	45609	-5285	-3333	-6752
Cash Flow from Financing Activitie	-39061	-775	-5205	-4418
Net Cash Inflow / Outflow	3893	194	2549	142

23%

Negative

Neutral

Positive

The stock has a PE ratio of -26.41.
3Y Stock Price CAGR of the stock is 46.5.
The stock has a beta of 1.0.
In the last financial year, the company had an EBITDA of ₹20353 Million.
The company generated revenue of ₹118131 Million in the previous financial year.

Glenmark Pharmaceuticals Ltd.

1405.15-17.1 (-1.2%)

₹

Investment Amount: ₹ 1000000

Current Value: ₹ 1516621.7

No. of Shares: 1079.3

Performance:51.7%

P/L: ₹516621.7